Metraipolis › archive › dc_881472ca1e8a

GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profiling — Europe PMC PMID:41536961

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41536961
DOI
10.1093/ehjopen/oeaf170
License (as archived)
solo-consultazione
Archived
2026-11-07T10:24:26.392Z
SHA-256 of the archived text
46a2d0334a8174a559c92acf510b0ade3f48f3f55338771f7935bc279a083334
Stable URL of this page
https://metraipolis.com/documento/dc_881472ca1e8a

How to cite

GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profiling — Europe PMC PMID:41536961 — Europe PMC (en), https://europepmc.org/article/MED/41536961 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_881472ca1e8a (Metraipolis archive dc_881472ca1e8a, sha256 46a2d0334a8174a559c92acf510b0ade3f48f3f55338771f7935bc279a083334)
BibTeX
@misc{dc881472ca1e8a,
  title = {GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profiling — Europe PMC PMID:41536961},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41536961},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_881472ca1e8a; sha256 46a2d0334a8174a559c92acf510b0ade3f48f3f55338771f7935bc279a083334},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41536961. Agents can read the archived copy with the MCP tool read_document.